PROMISSORY NOTEMetaStat, Inc. • June 24th, 2015 • Semiconductors & related devices • Delaware
ASET Therapeutics, LLC Suite 400 Walnut Creek, CA 94597 Effective as of May 31, 2015MetaStat, Inc. • June 24th, 2015 • Semiconductors & related devices
Reference is hereby made to that certain Memorandum of Understanding, dated as of July 14, 2014, by and among MetaStat, Inc., a Nevada corporation (“MetaStat”), MetaStat BioMedical, Inc., a Delaware corporation and a wholly-owned subsidiary of MetaStat (the “Subsidiary”), and Northstar Beacon, LLC, a Delaware limited liability company (“NORTHSTAR”), which entered into the Memorandum of Understanding with the express understanding and agreement among all the parties thereto that NORTHSTAR would assign all of its right, title and interest in and to the Memorandum of Understanding to ASET Therapeutics, LLC, a Delaware limited liability company (“ASET”), (such assignment was effectuated in December, 2014), and Amendments No. 1 and 2 to the Memorandum of Understanding (collectively, as so amended, the “MOU”). Each of MetaStat and ASET desire to clarify two provisions contained in the MOU so that there are no misunderstandings or doubt with regard thereto between the parties. Accordingly, th
PROMISSORY NOTEMetaStat, Inc. • June 24th, 2015 • Semiconductors & related devices • Delaware
